I guess following on from your question, is it possible any discoveries leading to drug developments could still lead back to pyc libraries and possible royalties? That would be interesting as i thought the deal was equity for access and pyc retain rights or options to any library content that ends up getting used? frustrating that so many others as shown here are making deals, yet here we are waiting to be told why the shareholder presentation and results scheduled in june have not appeared yet. Not only do we have no deals, again we have a missing or late data pack with no explanation where it went as yet. Seems strange you can announce via asx something will happen yet no obligation to explain down the track if it didnt happen.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)